About Sensydia
Sensydia is a company based in Los Angeles (United States) founded in 2015.. Sensydia has raised $17.8 million across 6 funding rounds from investors including NIH, HHS and Orlando Health. Sensydia offers products and services including Cardiac Performance System and Disposable Sensors. Sensydia operates in a competitive market with competitors including iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others.
- Headquarter Los Angeles, United States
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sensydia Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.8 M (USD)
in 6 rounds
-
Latest Funding Round
$3 M (USD), Grant
Jun 05, 2023
-
Investors
NIH
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sensydia
Sensydia offers a comprehensive portfolio of products and services, including Cardiac Performance System and Disposable Sensors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive platform for measuring cardiac metrics in clinical settings.
Components for accurate hemodynamic data acquisition in patient care.
Unlock access to complete
Unlock access to complete
Leadership Team
2 people
CTO Team
1 people
Advisor Team
1 people
CMO Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Sensydia
Sensydia has successfully raised a total of $17.8M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $3 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $3.0M
-
First Round
First Round
(01 Aug 2016)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Grant - Sensydia | Valuation |
investors |
|
| May, 2023 | Amount | Series A - Sensydia | Valuation | Orlando Health | |
| May, 2023 | Amount | Grant - Sensydia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sensydia
Sensydia has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Orlando Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to tech startups by Colle Capital.
|
Founded Year | Domain | Location | |
|
Early-stage investments are targeted by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sensydia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sensydia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sensydia Comparisons
Competitors of Sensydia
Sensydia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| domain | founded_year | HQ Location |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| domain | founded_year | HQ Location |
AI-based EGC data capture and analysis platform
|
|
| domain | founded_year | HQ Location |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| domain | founded_year | HQ Location |
Online health and wellness tracking and training platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sensydia
Frequently Asked Questions about Sensydia
When was Sensydia founded?
Sensydia was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Sensydia located?
Sensydia is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Who is the current CEO of Sensydia?
Anthony Arnold is the current CEO of Sensydia.
Is Sensydia a funded company?
Sensydia is a funded company, having raised a total of $17.8M across 6 funding rounds to date. The company's 1st funding round was a Grant of $605.54K, raised on Aug 01, 2016.
What does Sensydia do?
Sensydia was founded in 2015 in Los Angeles, United States, within the health technology sector. A wireless, non-invasive device for cardio-respiratory monitoring is being developed to allow real-time measurement of heart function in patients. Operations are maintained in stealth mode, with focus on medical device innovation for clinical applications. The company is led by CEO Anthony Arnold.
Who are the top competitors of Sensydia?
Sensydia's top competitors include AliveCor, iRhythm Tech and Biotricity.
What products or services does Sensydia offer?
Sensydia offers Cardiac Performance System and Disposable Sensors.
Who are Sensydia's investors?
Sensydia has 5 investors. Key investors include NIH, HHS, Orlando Health, Colle Capital, and Frontier Venture Capital.